Update on myocardial blood flow quantification by positron emission tomography

Area of Science:

• Cardiology
• Medical Imaging
• Nuclear Medicine

Background:

• Cardiovascular disease is a leading global cause of mortality.
• Ischemic heart disease is the primary cause, incurring significant healthcare costs.
• Cardiac imaging techniques have evolved for better patient assessment.

Purpose of the Study:

• To review the diagnostic and risk stratification utility of cardiac positron emission tomography (PET).
• To evaluate the role of myocardial blood flow and myocardial flow reserve quantification using cardiac PET.
• To compare the effectiveness of cardiac PET with other imaging modalities for coronary artery disease.

Main Methods:

• Review of existing literature on cardiac PET for coronary artery disease.
• Focus on quantitative assessment of myocardial blood flow (MBF) and myocardial flow reserve (MFR).
• Comparison of PET-derived parameters with outcomes and other imaging techniques.

Main Results:

• Cardiac PET is a powerful tool for diagnosing and stratifying risk in patients with ischemic heart disease.
• Quantification of MBF and MFR by cardiac PET provides detailed characterization of coronary artery disease.
• PET demonstrates particular value in assessing microvascular dysfunction and balanced multivessel disease.

Conclusions:

• Cardiac PET, especially through MBF and MFR quantification, offers superior diagnostic accuracy and risk assessment for coronary artery disease.
• This imaging modality provides critical insights beyond traditional methods, particularly for complex coronary artery disease patterns.
• The findings support the expanded use of cardiac PET in managing patients with suspected or confirmed coronary artery disease.